Jennifer M Kelly1, Jose M Ordovas1, Gregory Matuszek1, Caren E Smith1, Gordon S Huggins2, Hassan S Dashti3,4, Reiko Ichikawa1, Sarah L Booth1. 1. Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, 02111, USA. 2. Molecular Cardiology Research Institute Center for Translational Genomics, Tufts Medical Center and Tufts University, Boston, MA, 02111, USA. 3. Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. 4. Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
Abstract
SCOPE: A better understanding of factors contributing to interindividual variability in biomarkers of vitamin K can enhance the understanding of the equivocal role of vitamin K in cardiovascular disease. Based on the known biology of phylloquinone, the major form of vitamin K, it is hypothesized that plasma lipids contribute to the variable response of biomarkers of vitamin K metabolism to phylloquinone supplementation. METHODS AND RESULTS: The association of plasma lipids and 27 lipid-related genetic variants with the response of biomarkers of vitamin K metabolism is examined in a secondary analysis of data from a 3-year phylloquinone supplementation trial in men (n = 66) and women (n = 85). Year 3 plasma triglycerides (TG), but not total cholesterol, LDL-cholesterol, or HDL-cholesterol, are associated with the plasma phylloquinone response (men: β = 1.01, p < 0.001, R2 = 0.34; women: β = 0.61, p = 0.008, R2 = 0.11; sex interaction p = 0.077). Four variants and the TG-weighted genetic risk score are associated with the plasma phylloquinone response in men only. Plasma lipids are not associated with changes in biomarkers of vitamin K function (undercarboxylated osteocalcin and matrix gla protein) in either sex. CONCLUSION: Plasma TG are an important determinant of the interindividual response of plasma phylloquinone to phylloquinone supplementation, but changes in biomarkers of vitamin K carboxylation are not influenced by lipids.
SCOPE: A better understanding of factors contributing to interindividual variability in biomarkers of vitamin K can enhance the understanding of the equivocal role of vitamin K in cardiovascular disease. Based on the known biology of phylloquinone, the major form of vitamin K, it is hypothesized that plasma lipids contribute to the variable response of biomarkers of vitamin K metabolism to phylloquinone supplementation. METHODS AND RESULTS: The association of plasma lipids and 27 lipid-related genetic variants with the response of biomarkers of vitamin K metabolism is examined in a secondary analysis of data from a 3-year phylloquinone supplementation trial in men (n = 66) and women (n = 85). Year 3 plasma triglycerides (TG), but not total cholesterol, LDL-cholesterol, or HDL-cholesterol, are associated with the plasma phylloquinone response (men: β = 1.01, p < 0.001, R2 = 0.34; women: β = 0.61, p = 0.008, R2 = 0.11; sex interaction p = 0.077). Four variants and the TG-weighted genetic risk score are associated with the plasma phylloquinone response in men only. Plasma lipids are not associated with changes in biomarkers of vitamin K function (undercarboxylated osteocalcin and matrix gla protein) in either sex. CONCLUSION: Plasma TG are an important determinant of the interindividual response of plasma phylloquinone to phylloquinone supplementation, but changes in biomarkers of vitamin K carboxylation are not influenced by lipids.
Authors: Hassan S Dashti; M Kyla Shea; Caren E Smith; Toshiko Tanaka; Adela Hruby; Kris Richardson; Thomas J Wang; Mike A Nalls; Xiuqing Guo; Yongmei Liu; Jie Yao; Dalin Li; W Craig Johnson; Emelia J Benjamin; Stephen B Kritchevsky; David S Siscovick; José M Ordovás; Sarah L Booth Journal: Am J Clin Nutr Date: 2014-10-08 Impact factor: 7.045
Authors: Shafqat Ahmad; Samia Mora; Paul W Franks; Marju Orho-Melander; Paul M Ridker; Frank B Hu; Daniel I Chasman Journal: Clin Chem Date: 2017-11-02 Impact factor: 8.327
Authors: M Kyla Shea; Sarah L Booth; Jennifer A Nettleton; Gregory L Burke; Haiying Chen; Stephen B Kritchevsky Journal: J Nutr Date: 2012-04-11 Impact factor: 4.798
Authors: Sarah L Booth; Gerard Dallal; M Kyla Shea; Caren Gundberg; James W Peterson; Bess Dawson-Hughes Journal: J Clin Endocrinol Metab Date: 2008-02-05 Impact factor: 5.958
Authors: Frida Renström; Dmitry Shungin; Ingegerd Johansson; Jose C Florez; Göran Hallmans; Frank B Hu; Paul W Franks Journal: Diabetes Date: 2010-09-24 Impact factor: 9.461
Authors: Jennifer M Kelly; Gregory Matuszek; Tim J van den Broek; Gordon S Huggins; Caren E Smith; Jose M Ordovas; Suzan Wopereis; Sarah L Booth Journal: Curr Dev Nutr Date: 2020-06-11